These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36245227)

  • 21. LncRNA SLC25A21-AS1 increases the chemosensitivity and inhibits the progression of ovarian cancer by upregulating the expression of KCNK4.
    Huang K; Chen X; Geng Z; Xiong X; Cong Y; Pan X; Liu S; Ge L; Xu J; Jia X
    Funct Integr Genomics; 2023 Mar; 23(2):110. PubMed ID: 36995496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a.
    Lin C; Zheng M; Yang Y; Chen Y; Zhang X; Zhu L; Zhang H
    Bioengineered; 2022 Apr; 13(4):9829-9838. PubMed ID: 35412951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer.
    Zhang Q; Yan G; Lei J; Chen Y; Wang T; Gong J; Zhou Y; Zhao H; Chen H; Zhou Y; Wu L; Zhang J; Zhang X; Wang J; Li Y
    Mol Med; 2020 May; 26(1):39. PubMed ID: 32375633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.
    Miao JT; Gao JH; Chen YQ; Chen H; Meng HY; Lou G
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer.
    Shao Y; Li H; Wu Y; Wang X; Meng J; Hu Z; Xia L; Cao S; Tian W; Zhang Y; Feng X; Zhang X; Li Y; Yang G
    Cancer Lett; 2023 Jul; 565():216241. PubMed ID: 37217070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.
    Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ
    Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
    Miao S; Wang J; Xuan L; Liu X
    Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
    Chang H; Li B; Zhang X; Meng X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
    Bley N; Schott A; Müller S; Misiak D; Lederer M; Fuchs T; Aßmann C; Glaß M; Ihling C; Sinz A; Pazaitis N; Wickenhauser C; Vetter M; Ungurs O; Strauss HG; Thomssen C; Hüttelmaier S
    RNA Biol; 2021 Mar; 18(3):391-403. PubMed ID: 32876513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
    Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the lncRNA ABHD11-AS
    Wu DD; Chen X; Sun KX; Wang LL; Chen S; Zhao Y
    Mol Cancer; 2017 Aug; 16(1):138. PubMed ID: 28818073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer.
    Zhu Q; Zhang C; Qu T; Lu X; He X; Li W; Yin D; Han L; Guo R; Zhang E
    Cancer Res; 2022 Dec; 82(23):4340-4358. PubMed ID: 36214649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.
    Zhang Z; Yang W; Li N; Chen X; Ma F; Yang J; Zhang Y; Chai X; Zhang B; Hou X; Luo S; Hua Y
    Carcinogenesis; 2021 Feb; 42(2):263-271. PubMed ID: 32860508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
    Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
    Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
    Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
    Cui S
    J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9.
    Wang X; Yang B; She Y; Ye Y
    J Cell Biochem; 2018 Sep; 119(9):7790-7799. PubMed ID: 29904939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.